Get started
Author

Ahmed Hussein Zedan

Observed names: A. H. Zedan, A.H.R. Zedan, Ahmed H. Zedan, Ahmed Zedan, Zedan AH, Zedan, Ahmed, Zedan, Ahmed H.
ORCID: 0000-0002-8895-6394
Observed ORCID: 0000-0002-8895-6394
OpenAlex ID: A5036794838
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
2020 · A. H. Zedan, P. J. S. Osther, et al. · Scientific Reports · 81
PDF
Drug‐Induced Peripheral Neuropathy
2014 · Ole Jakob Vilholm, Alex Alban Christensen, et al. · Basic & Clinical Pharmacology & Toxicology · 77
PDF
Oxaliplatin-Induced Neuropathy in Colorectal Cancer: Many Questions With Few Answers
2013 · Ahmed Hussein Zedan, Torben Frøstrup Hansen, et al. · Clinical Colorectal Cancer · 64
microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer
2018 · Ahmed Hussein Zedan, Torben Frøstrup Hansen, et al. · Tumor Biology · 48
PDF
Electrochemical sensors for screening of tyrosine and tryptophan as biomarkers for diseases: A narrative review
2023 · Hashmatullah Nasimi, Jonna Skov Madsen, et al. · Microchemical Journal · 46
PDF
Circulating miRNAs in localized/locally advanced prostate cancer patients after radical prostatectomy and radiotherapy
2018 · Ahmed H. Zedan, Torben F. Hansen, et al. · The Prostate · 40
PDF
Correlation between stage of prostate cancer and tyrosine and tryptophan in urine samples measured electrochemically
2022 · Hashmatullah Nasimi, Jonna Skov Madsen, et al. · Analytical Biochemistry · 26
Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations
2017 · Ahmed Hussein Zedan, Søren Garm Blavnsfeldt, et al. · PLoS ONE · 25
PDF
Protein biomarker detection in prostate cancer: A comprehensive review of electrochemical biosensors
2023 · Hashmatullah Nasimi, Jonna Skov Madsen, et al. · Sensors and Actuators Reports · 23
PDF
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer
2019 · Torben Frøstrup Hansen, Line Nederby, et al. · Translational Oncology · 23
PDF
Identification of early stage and metastatic prostate cancer using electrochemical detection of beta-2-microglobulin in urine samples from patients
2023 · Hashmatullah Nasimi, Jonna Skov Madsen, et al. · Scientific Reports · 13
PDF
Chemotherapy‐Induced Polyneuropathy: Major Agents and Assessment by Questionnaires
2014 · Ahmed H. Zedan, Ole J. Vilholm · Basic & Clinical Pharmacology & Toxicology · 11
Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide
2023 · A. H. Zedan, L. Nederby, et al. · Scientific Reports · 7
PDF
NK Cell-Microbiota Interaction Biomarker Strategy: Advancing Prostate Cancer Management
2025 · Sara Fanijavadi, Torben Frøstrup Hansen, et al. · Biomolecules · 6
PDF
Patient-reported lower limb edema after primary radiotherapy for prostate cancer
2023 · Lars Fokdal, Martin Berg, et al. · Acta Oncologica · 5
Methylation-specific, universal, and highly sensitive identification of ctDNA in prostate cancer by multiplex droplet digital PCR
2026 · Søren Kahns, Ahmed H. Zedan, et al. · PLoS ONE · 2
PDF
Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints
2025 · Ellen Lund Schaldemose, Christine Vestergaard Madsen, et al. · Acta Oncologica · 2
PDF
Cabazitaxel-induced ureteritis in metastatic castration-resistant prostate cancer patients: a single center case series 2014–2024
2025 · Ahmed H. Zedan, Jesper S. Gade, et al. · Cancer Imaging · 2
PDF
Pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with docetaxel-pretreated, metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort E.
2024 · Marinela Augustin, Brigitte Laguerre, et al. · Journal of Clinical Oncology · 2
PDF
Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer
2026 · Karoline Kondrup, Laura Iisager, et al. · British Journal of Cancer · 1
PDF
Tyrosine and tryptophan in urine as biomarkers for prostate cancer: A validation study
2024 · Hashmatullah Nasimi, Jonna Skov Madsen, et al. · Journal of Pharmaceutical and Biomedical Analysis · 1
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers
2024 · Carlos Berenguer Albiñana, Matteo Pallocca, et al. · Applied Clinical Informatics · 1
PDF
Survival outcomes for metastatic castration sensitive prostate cancer: Real world data from a Danish cohort 2016-2022.
2024 · Ahmed H. Zedan, Torben Hansen, et al. · Journal of Clinical Oncology · 1
PDF
The Current Role of Immunotherapy in mCRPC: A Systematic Review
2021 · Dalibey H, Hansen TF, et al. · Austin Journal of Clinical Case Reports · 1
Clinical significance of circulating macrophage markers across different stages of prostate cancer: highlighting soluble CD163
2026 · Emma B. Hansen, Kristian W. Antonsen, et al. · British Journal of Cancer
Works count: 43
Citation count: 508
H-index: 11
I10-index: 12
Year
Topic
Type